Deal Library / Pharma BD Deal Intelligence

Cubist Pharmaceuticals, Inc. — Pharma Deals

The Pharma Closeout tracks 4 deals, $2.3B in disclosed deal value, 4 with a post-close Outcome Score for Cubist Pharmaceuticals, Inc..

Median Critic Score: 86  ·  Median Outcome Score: 47

Best outcome: Cubist Pharmaceuticals, Inc. / Calixa Therapeutics, Inc. (52)  ·  Weakest outcome: Cubist Pharmaceuticals, Inc. / Trius Therapeutics Inc. (44)

All 4 deals

• Cubist Pharmaceuticals, Inc. / Calixa Therapeutics, Inc. — 2009 · $402M · Mixed — partial payoff, real shortfalls.
• Cubist Pharmaceuticals, Inc. / Adolor Corporation — 2011 · $415M · Mixed — partial payoff, real shortfalls.
• Cubist Pharmaceuticals, Inc. / Optimer Pharmaceuticals, Inc. — 2013 · $801M · Mixed — partial payoff, real shortfalls.
• Cubist Pharmaceuticals, Inc. / Trius Therapeutics Inc. — 2013 · $707M · Underwhelmed — fell short of the thesis.

← Deal Library  ·  Interactive search  ·  How we score deals